313 related articles for article (PubMed ID: 20479907)
1. Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.
Kim ES; Kim WH
Gut Liver; 2010 Mar; 4(1):1-14. PubMed ID: 20479907
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology and the pathogenesis of inflammatory bowel disease.
Karlinger K; Györke T; Makö E; Mester A; Tarján Z
Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.
Kirsner JB
Dis Mon; 1991 Nov; 37(11):669-746. PubMed ID: 1935537
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends of inflammatory bowel disease in South Korea: A nationwide population-based study.
Kwak MS; Cha JM; Lee HH; Choi YS; Seo SI; Ko KJ; Park DI; Kim SH; Kim TJ
J Gastroenterol Hepatol; 2019 Jun; 34(6):1018-1026. PubMed ID: 30447025
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease. Part I: Nature and pathogenesis.
Kirsner JB
Dis Mon; 1991 Oct; 37(10):605-66. PubMed ID: 1893828
[TBL] [Abstract][Full Text] [Related]
8. Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania.
Goldiș A; Lupușoru R; Gheorghe L; Gheorghe C; Trifan A; Dobru D; Cijevschi C; Tanțău A; Constantinescu G; Iacob R; Goldiș R; Diculescu M
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635181
[No Abstract] [Full Text] [Related]
9. Inflammatory bowel disease in children--clinical, endoscopic, radiologic and histopathologic investigation.
Seo JK; Yeon KM; Chi JG
J Korean Med Sci; 1992 Sep; 7(3):221-35. PubMed ID: 1285921
[TBL] [Abstract][Full Text] [Related]
10. Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.
Romeo S; Neri B; Mossa M; Calabrese E; Lolli E; Sena G; Gesuale C; Chiaramonte C; Biancone L
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):844-851. PubMed ID: 33136723
[TBL] [Abstract][Full Text] [Related]
11. [Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)].
Jantchou P; Monnet E; Carbonnel F
Gastroenterol Clin Biol; 2006; 30(6-7):859-67. PubMed ID: 16885870
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review and update on Crohn's disease.
Gajendran M; Loganathan P; Catinella AP; Hashash JG
Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
[TBL] [Abstract][Full Text] [Related]
13. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
14. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
15. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease.
Cui G; Yuan A
Front Med (Lausanne); 2018; 5():183. PubMed ID: 29971235
[No Abstract] [Full Text] [Related]
17. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
18. Familial occurrence and inheritance studies in inflammatory bowel disease.
Binder V; Orholm M
Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
[TBL] [Abstract][Full Text] [Related]
19. Urotensin II levels in patients with inflammatory bowel disease.
Alicic D; Martinovic D; Rusic D; Zivkovic PM; Tadin Hadjina I; Vilovic M; Kumric M; Tokic D; Supe-Domic D; Lupi-Ferandin S; Bozic J
World J Gastroenterol; 2021 Sep; 27(36):6142-6153. PubMed ID: 34629825
[TBL] [Abstract][Full Text] [Related]
20. Approach to a Child with Colitis.
Palle SK; Prasad M; Kugathasan S
Indian J Pediatr; 2016 Nov; 83(12-13):1444-1451. PubMed ID: 27080713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
